Starting a DMARD Early in Rheumatoid Arthritis Doubles the Chances of It Working (Even in ‘Seronegative’ Patients)
December 10, 2019
These findings confirm that the usual treatment strategy in RA — early treatment, tight control, and treat to target — should be applied similarly to both seropositive and seronegative diseases.
Continue reading